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Microglia play critical roles in neural development, homeostasis and 
neuroinflammation and are increasingly implicated in age-related neurological 
dysfunction.  Neurodegeneration often occurs in disease-specific spatially-restricted 
patterns, the origins of which are unknown. We performed the first genome-wide 
analysis of microglia from discrete brain regions across the adult lifespan of the 
mouse and reveal that microglia have distinct region-dependent transcriptional 
identities and age in a regionally variable manner. In the young adult brain, 
differences in bioenergetic and immunoregulatory pathways were the major sources 
of heterogeneity and suggested that cerebellar and hippocampal microglia exist in a 
more immune vigilant state. Immune function correlated with regional transcriptional 
patterns. Augmentation of the distinct cerebellar immunophenotype and a 
contrasting loss in distinction of the hippocampal phenotype among forebrain regions 
were key features during ageing. Microglial diversity may enable regionally localised 
homeostatic functions but could also underlie region-specific sensitivities to 











Microglia are a specialised population of tissue macrophages resident in the central 
nervous system (CNS) parenchyma and adapted to the unique properties of the 
CNS environment1. Recent studies have revealed an expanding array of functions 
for microglia during brain development and adult homeostasis and in 
neurodegeneration, infection and brain injury2. These studies have shown that the 
cellular activities of microglia extend beyond their well-established role as immune 
sentinels and effectors to include synaptic organisation3, 4, control of neuronal 
excitability5, phagocytic debris removal6 and trophic support for brain protection and 
repair7, 8.  
The multifunctional roles of microglia may be considered part of a spectrum of 
environmental monitoring that is designed to sense perturbations and elicit 
appropriate microglial responses to maintain homeostasis. The local environment will 
therefore be a key influence shaping microglial phenotype. Notably, exposure to 
neuronal cell surface and soluble factors has been shown to maintain microglia in a 
comparatively quiescent immunophenotype (versus systemic macrophage 
populations)9, 10. Recent studies have extended these findings to describe key 
features of the genome-wide transcriptional profile of microglia that distinguishes 
their phenotype from non-CNS macrophages11, 12.  
The microenvironment is not uniform throughout the various brain regions. 
Variations in neuronal subtypes, neurotransmitter profiles, haemodynamics and 
metabolism could all be an influence on and be influenced by local microglial 
phenotype. Moreover, the permeability of the blood-brain barrier and resultant 
exposure to systemic signals that can also modify microglial phenotype are 
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regionally heterogeneous. It remains unclear if microglial phenotype is similarly 
diverse throughout the brain. Regional variations in microglial density13, surface 
expression of a small panel of immune molecules14, and dependency on 
maintenance by IL-3415, 16 suggest there could be differences.  
Ageing is associated with alterations in the neuroinflammatory environment and 
recent studies have uncovered risk alleles in age-related neurodegenerative disease 
that implicate microglial dysfunction and neuroinflammatory processes as 
contributory factors17. The pathological targeting and progression of most 
neurodegenerative conditions occurs in region-specific patterns and regulatory 
mechanisms of gene expression in the human brain were recently shown to have 
regional differences18. This suggests that it is important to determine if ageing 
modifies any region-specific influences on microglial phenotype. 
Here we have used genome-wide transcriptional profiling of adult microglia from 
discrete brain regions at three different ages in combination with network analyses to 
determine the nature of microglial diversity in the adult mouse brain and the impact 
of ageing. To our knowledge, these data provide the first account of the microglial 
regional transcriptome throughout the adult lifespan. Our data reveal microglia as 
richly diverse cells under steady-state conditions, show that microglial ageing occurs 
non-uniformly in a region-dependent manner, and define the transcriptional basis 
and major functional features responsible for this region- and age-related diversity. 
Our datasets provide an extensive and publically-accessible comparative resource 
for future studies exploring microglial function, dysfunction and contribution to age-





Isolation of adult microglia from discrete brain regions 
We refined established techniques to purify adult mouse microglia by density 
gradient and immuno-magnetic separation (Fig 1 and Supplementary Fig 1a). We 
first validated the consistency of microglial extraction from all regions of interest 
(cerebellum, cerebral cortex, hippocampus, striatum). The CD11b antigen is 
ubiquitously expressed on microglia throughout all brain regions as shown by 
colocalisation with GFP+ microglia in the Csf1r-EGFP “MacGreen” reporter mouse 
(Supplementary Fig 1b). The post-purified selected fraction consisted of a single 
population of CD11b+ and F4/80+ cells and there was no detectable CD11b or F4/80 
staining in the post-purified non-selected fraction confirming CD11b as an efficient 
target for purification (Supplementary Fig 1c).  Microglia obtained from all regions 
showed a uniform CD11b+F4/80+CD45lo profile (Fig 1a) characteristic of resident 
brain microglia and distinguishing them from CD45hi systemic macrophage 
populations. This indicated that we were extracting an equivalent microglial 
population from all brain regions. Expression of Itgam (encodes CD11b) and other 
established microglial/macrophage genes including Csf1r and Cx3cr1 was similarly 
enriched in purified microglia from each region in comparison to the respective mixed 
brain cell homogenates (Fig 1b). Additional genes recently reported as microglial 
“signature” genes (e.g. Tmem119, P2ry13)11, 12, 19 were also highly enriched in 
purified samples (Fig 1c) whereas markers of neurons, astrocytes and 
oligodendrocytes were expressed at negligible levels in purified microglia (Fig 1d). 
Genes highly expressed in blood leukocyte subsets including Cd3e (T lymphocytes), 
Cd19 (B lymphocytes) and Ly6g (granulocytes) were undetectable in purified 
microglia (Fig 1e) and there was no expression of systemic macrophage-specific 
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genes identified from a recent study (e.g. Fabp4, Serpinb2)11 in microglial samples 
(Fig 1f). Immunostaining of isolated cells in culture showed that all cells stained 
positively for the microglial/macrophage antigens IBA1 and F4/80 (Fig 1g). Together 
these data verify the purity and consistency of microglial extraction across brain 
regions.  
 
The microglial transcriptome is regionally heterogeneous  
We initially determined whether the microglial transcriptome in the healthy young 
adult brain (4 months of age) is regionally heterogeneous. Principal components 
analysis (PCA) showed clustering of samples in a region-dependent manner and 
indicated a close relationship between microglial expression profiles of the cerebral 
cortex and striatum and relatively more distinct profiles in the cerebellum and 
hippocampus (Fig 2a). These relationships were validated non-subjectively using the 
network visualisation and analysis tool BioLayout Express3D 
(http://www.biolayout.org/). Sample-to-sample correlation analysis showed clustering 
according to brain region with similar inter-regional relationships as PCA (Fig 2b). 
Thus, the global gene expression profile of adult microglia in the healthy brain is 
regionally heterogeneous. 
Expression of 3,131 probesets (~7% of total) representing 2527 genes was 
differentially regulated by brain region (FDR q < 0.05) (Supplementary Table 1). 
Hierarchical clustering of samples based on differentially expressed probesets 
demonstrated the marked contrast in expression profile between cortical/striatal and 
cerebellar microglia and the intermediate profile in hippocampal microglia (Fig 2c). 
Genes involved in multiple aspects of immune function were among the most 
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differentially expressed by region (Supplementary Table 1) including those with 
established function and others previously unexplored in microglia. Analysis of Gene 
Ontology (GO) biological processes using DAVID revealed “immune response” and 
“immune effector response” as significantly over-represented (Supplementary 
Table 2). There was also a striking over-representation of multiple processes 
associated with energy metabolism (Supplementary Table 2). We used the 
Enrichment Map (http://baderlab.org/Software/EnrichmentMap/) network 
visualisation tool to remove redundancy in GO enrichment annotation. The key 
feature of the network was the presence of two major clusters each comprising 
functionally-related and highly-connected enriched gene sets with roles in immune 
function and energy metabolism (Fig 2d). Full annotation of nodes within these 
clusters is presented in Supplementary Table 3. These data indicated 
immunoregulatory and bioenergetic/metabolic processes as the major contributors to 
regional diversity in microglial phenotype of the young adult brain.  
 
Three major patterns of region-dependent microglial gene co-expression 
We next sought to define the region-specific microglial phenotypes by assessing 
patterns of gene co-expression using BioLayout Express3D 
(http://www.biolayout.org/)20. The utility of BioLayout Express3D for the identification 
of spatiotemporal patterns of gene expression and the discovery of transcriptional 
networks underpinning common functional pathways has been described 
previously20. A network graph constructed from the set of 3,131 regionally 
differentially expressed probesets was clustered using a Markov clustering algorithm 
to non-subjectively sub-divide the graph into discrete sets of co-expressed genes. 
Overall graph structure consisted of 14 clusters ranging in size from 10 to >1,000 
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nodes (Fig 3a and Supplementary Fig 2a). Three major clusters distributed across 
two distinct regions of the graph were evident (Fig 3a and Supplementary Table 4). 
The mean expression profiles of these three clusters showed that cluster 1 contained 
genes whose expression was relatively greater in cerebral cortex and lower in 
cerebellum (Fig 3b). In contrast, clusters 2 and 3, which were located together and 
distant from cluster 1, both contained genes with relatively greater expression in the 
cerebellum (with greater hippocampal expression in cluster 2). The expression 
profile for individual genes within each cluster generally followed the cluster mean 
(Fig 3c). Increasing the Pearson correlation threshold did not materially affect the 
overall graph or clustering structure (Supplementary Fig 2) 
 
Microglial immunophenotyppic and bioenergetic heterogeneity 
Genes which share highly correlated expression profiles across a range of 
experimental conditions (i.e. are co-expressed) are often distinct components of a 
common pathway or biological process21. A large number of cluster 3 genes (high 
expression in cerebellum) were immune-related. GO analysis revealed “immune 
response” and “defence response” as the most overrepresented biological processes 
(Supplementary Table 5) and clustering using Enrichment Map underlined the array 
of enriched immune-related processes (Fig 4a). To gain further insight to the 
molecular functions encoded in cluster 3, we manually annotated genes according to 
the following major categories: pathogen/self-recognition, cell adhesion and 
chemotaxis, signalling integration, antigen presentation, and microbial 
killing/sequestration (Fig 4b). Genes from multiple molecular classes involved in 
pathogen (or self) recognition were present in cluster 3. Bacterial recognition genes 
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included the C type lectins (Clec4e (Mincle), Clec7a (Dectin 1), Cd209a (DC-SIGN)) 
and Fcnb (Ficolin B) and the formyl peptide receptors Fpr1 and Fpr2. Viral 
recognition was also evident in the high expression of the Zbp1 gene, which encodes 
cytoplasmic sensors of viral DNA22. Consistent with antiviral activity, there were a 
large number of interferon pathway genes (e.g. Stat1, Stat4, Ifit2, Ifitm3, Irf7, Oas1, 
Plscr1) and pathway analysis in Ingenuity identified an enriched interferon network 
and both interferon gamma and the type I interferon receptor (IFNAR) as top 
upstream regulators (Supplementary Fig 3 and Supplementary Table 6). A 
striking feature of cluster 3 was the presence of multiple genes involved in antigen 
processing and presentation, including both MHC-I (H2-D1, H2-K1) and MHC-II (H2-
Aa, H2-Ab1, H2-Eb1, Cd74) pathways. Upstream regulation was evident through the 
presence of Ciita encoding the master regulator of MHC-II expression and Nlrc5, the 
master regulator of MHC-I gene expression. Pathway analysis in KEGG identified 
antigen processing and presentation as a significantly over-represented pathway 
(Supplementary Fig 4 and Supplementary Table 7). Genes encoding several 
classes of immune effector molecules, many involved in pathogen killing or 
sequestration, were present in this cluster. Camp and Ngp, genes encoding the anti-
microbial peptides mCRAMP and neutrophilic granule protein respectively, were of 
particular note because a recent study identified these genes as unexpectedly highly 
expressed in microglia compared to non-CNS macrophages11. The regional 
expression profile of selected genes from cluster 3 was further assessed by 
quantitative PCR (Fig 4c) and at the protein level by flow cytometry with both 
demonstrating comparable profiles to the microarray data (Fig 4d, e). We also noted 
a panel of immunoregulatory molecules in cluster 1 (relatively high expression in 
cortex and low in cerebellum) indicating that some immunoregulatory pathways may 
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be more active in regions other than the cerebellum (see below also). These were 
largely immune signalling genes (e.g. Cd47, Cd300a) encoding molecules that limit 
the strength of myeloid cell responses to external stimuli.  
The bioenergetic profile of myeloid cells is tightly linked to their 
immunophenotype and the environmental conditions they are exposed to (e.g. 
normoxia/hypoxia)23. We were therefore interested that cluster 2 (high expression in 
cerebellum and hippocampus) contained a large number of genes associated with 
key components of energy production systems and their regulation (Fig 4f-h). This 
was validated by GO analysis which revealed “generation of precursor metabolites 
and energy”, “electron transport chain” and “oxidative” phosphorylation” as among 
the most highly over-represented processes (Supplementary Table 8) and 
visualisation in Enrichment Map showed multiple clusters associated with glycolysis, 
the electron transport chain, ATP synthesis and redox metabolic activity (Fig 4f). 
Genes encoding most enzymes in the glycolytic pathway, the tricarboxylic acid 
(TCA) cycle, multiple subunit constituents of each of the proton pump complexes in 
the electron transport chain (I, III, IV) and the ATP synthase complex were present in 
cluster 2 (Fig 4g). Key regulators of energy metabolism were also present, notably 
peroxisome proliferator-activated receptor gamma (Pparg) and the associated co-
activator peroxisome proliferator-activated receptor gamma coactivator 1-alpha 
(Ppargc1a), which co-operate to control transcription of an array of genes involved in 
mitochondrial function and energy metabolism. Antioxidant responses, important for 
counteracting oxygen radicals produced during oxidative phosphorylation, were also 
represented, including the superoxide dismutase (Sod1, Sod2), catalase (Cat), 
peroxiredoxin (Prdx2, Prdx5) and glutathione peroxidase (Gpx4, Gpx8) families (Fig 
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4g). Individual gene expression profiles of representative examples for each of the 
above classes are shown in Fig 4h.  
Collectively, the above data support the suggestion that cerebellar and 
hippocampal microglia maintain a more immune-alert state than microglia in the 
striatum and cortex and this is accompanied by relatively greater expression of an 
extensive set of co-regulated genes involved in energy metabolism. 
 
Microglial steady-state heterogeneity in immune alertness  
Immune cells maintain a balance between activating and inhibitory signals to fine-
tune the strength of their responses in part through cell surface activating receptors 
that associate with immunoreceptor tyrosine-based activation motifs (ITAMs) and 
counteracting inhibitory receptors containing immunoreceptor tyrosine-based 
inhibition motifs (ITIMs)24. Given the more immune-alert state of cerebellar and 
hippocampal microglia suggested above, we explored whether there were regional 
differences in microglial expression of ITAM-associating and ITIM-containing 
immunoreceptors. We focussed on the triggering receptor expressed on myeloid cell 
(TREM), sialic acid-binding immunoglobulin-type lectins (Siglec), CD200R, CD300 
and signal regulatory peptide (SIRP) families, each of which contains activating and 
inhibitory members  (Fig 5a). In all families, we found inter-regional differences in 
expression of both ITAM and ITIM-signalling members and strikingly there was an 
opposing pattern of expression for activating and inhibitory receptors (Fig 5b, c). 
Activating ITAM-associating members were more highly expressed in cerebellar 
microglia whereas ITIM-containing inhibitory members showed the reverse pattern. 
For example, in the CD300 family, CD300a is the only member with a cytoplasmic 
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tail containing an ITIM motif and Cd300a was expressed at lower levels in 
cerebellum and hippocampus. In contrast, other CD300 members have consensus 
sequences enabling association with ITAM-containing adapters such as DAP12 and 
all showed the opposite pattern of expression to Cd300a. One caveat relates to 
TREM2, which although associating with the ITAM-containing DAP12 adapter 
molecule, dampens microglial pro-inflammatory reactions, and thus the expression 
profile is consistent with other inhibitory immunoreceptors. Expression of the genes 
encoding the ITAM-containing adapter proteins DAP12 and DAP10 was consistent 
across brain regions, perhaps reflecting their common use for signalling by several 
receptors (Fig 5a). 
We next determined if the regional immunophenotypes of microglia extended to 
differences resembling overtly polarised states of microglia activation. We mined 
published microglial microarray datasets25 to establish a set of non-overlapping 
genes induced by classical (LPS) or alternative (IL-4) activation. This identified 216 
LPS-induced genes and 132 IL-4-induced genes (Fig 5d). 17% of these LPS-
induced genes and 18% of IL-4-induced genes were differentially expressed 
according to brain region in the present study. The LPS-inducible subset showed 
greater expression of the majority of genes in the cerebellum and hippocampus (Fig 
5e). In contrast, greater expression of the differentially expressed subset of IL-4-
inducible genes was not restricted to any particular brain region (Fig 5f). 
Furthermore, the majority of microglial genes associated with classical or alternative 
activation were expressed at almost undetectable levels in all brain regions, 
including the archetypal marker genes Nos2 and Arg1 (Fig 5g). Thus it appears the 
more “alert” phenotype of microglia in the cerebellum and hippocampus is distinct 
from conventional states of activation or polarisation. 
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We reasoned that steady-state differences in microglial immune alertness could 
predispose to region-dependent variations in function. To assess this directly, it was 
important to use an assay with freshly isolated microglia (prepared as for microarray) 
exposed to an equivalent challenge and over a short timeframe to avoid prolonged 
culturing which could result in de-differentiation from in vivo regional phenotypes. We 
achieved this using a bacterial phagocytosis and replication assay. Fewer bacteria 
were recovered from cortical microglia than cerebellar microglia 1 h after gentamicin 
treatment (Fig 5h), which may reflect distinct phagocytic or killing capacity, or both. 
Relative to the population of bacteria present inside microglia at 1 h after gentamicin 
treatment, there was a significant increase in intracellular net replication of bacteria 
in cortical but not cerebellar microglia by 4 h (Fig 5h). This suggested that cerebellar 
microglia were better able to control the net replication of internalized bacteria and 
support distinct functional responses of microglia to challenge that correlate with 
their region-specific immune alertness transcriptional profiles. 
 
Transcriptional regulators of region-dependent co-expression networks 
As described above, clusters 2 and 3 contained genes encoding known 
transcriptional regulators (e.g. Pparg, Nlrc5) of many of the respective cluster genes. 
To gain further insight to transcriptional control mechanisms that may drive microglial 
diversity we searched the annotated promoter regions of genes within these clusters 
for over-representation of transcription factor binding (TFB) motifs from the JASPAR 
collection26 using Clover27. Motifs recognised by the specificity protein (Sp), nuclear 
hormone receptor 4A (NR4A), estrogen related receptor (ERR) and RAR-related 
orphan receptor (ROR) were significantly over-represented in cluster 2 
(Supplementary Table 9). Each of these families has established roles in regulating 
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cellular energy metabolism28-31 which is consistent with the prominence of 
bioenergetic genes in cluster 2. The NR4A, ERR and ROR transcription factors are 
all members of the nuclear receptor family that act as both metabolic sensors and 
transcriptional regulators32, perhaps highlighting how the metabolic environment of 
microglia could direct region-dependent regulation of gene expression. TFB motifs 
over-represented in cluster 3 included those bound by early B-cell factor-1 (EBF1), 
forkhead box L1 (FOXL1), activator protein 1 (AP1) and c-Rel (REL) 
(Supplementary Table 9) all of which are known regulators of immune and 
inflammatory gene expression33-35 and therefore consistent with the 
immunoregulatory gene profile of cluster 3.    
 
Brain region disproportionately affects cell surface gene expression  
A subset of genes encoding microglial cell surface proteins was described recently11 
and  termed the microglial “sensome” with reference to their  involvement in sensing 
the environment. We hypothesised that brain region would have a substantial impact 
on the expression of the sensome genes given that regional heterogeneity of 
microglial phenotype may in part arise from exposure to varying local environmental 
demands. GO terms associated with the cell surface were highly enriched in the set 
of regional differentially expressed genes (Supplementary Fig 5a) and 34 of the 100 
sensome genes were differentially expressed according to brain region. The majority 
were expressed at greater levels in the striatum and cortex (Supplementary Fig 5b) 
and related to immune signalling (Supplementary Table 10). Moreover, of the 
differentially-regulated sensome genes involved in immune signalling, many encoded 
proteins involved in restricting over-activation of microglia, including Cx3cr1, Trem2, 
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Cd33, Siglech and Fcgr2b (Supplementary Fig 5c). These data highlight that brain 
region has a disproportionately large effect on expression of genes encoding 
microglial cell surface proteins (compared to all genes) and that much of the 
heterogeneity affects receptors transducing microglial “off” signals10. 
Transmembrane pathways promoting microglial quiescence may therefore be active 
at differing levels depending on brain localisation and contribute to regional 
differences in immune alertness.     
 
Inter-regional microglial heterogeneity mirrors macrophage tissue diversity 
We assessed the extent of inter-regional microglial heterogeneity in the wider 
context of macrophage diversity by comparison of our regional microglial 
transcriptomes with selected purified macrophage datasets from the GNF Mouse 
GeneAtlas V3 (http://biogps.org/dataset/2394/gnf-mouse-geneatlas-v3/) acquired on 
the same microarray platform. As anticipated, using PCA the 1st principal component 
distinguished macrophage populations (peritoneal and bone marrow) from all 
microglial samples (Fig 6a). The 2nd principal component identified inter-regional 
heterogeneity in microglia that was comparable in magnitude to the differences 
between bone marrow and peritoneal macrophages.  In view of the established 
diversity of tissue macrophages outside the brain, these data give an indication of 
the extent of inter-regional microglial heterogeneity discovered in the present study. 
We next determined the genes which were most highly expressed (>10-fold, FDR q 
< 0.05) in microglia compared to macrophages and if these were commonly found in 
microglia from all regions. Microglia from all regions each expressed a similar 
number of microglial-enriched genes (Fig 6b). Greater than 90% of these were 
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common to at least two regions of the brain and approximately two-thirds to microglia 
from all regions (Fig 6c). Among these were genes recently identified as 
distinguishing microglia from macrophages including P2ry12, Tmem119 and 
Olfml311, 12, 19 (Fig 6d). Thus, in the healthy young adult brain, microglia express 
considerable regional heterogeneity yet retain a unifying core profile that, regardless 
of brain region, distinguishes them from tissue macrophages outside the brain. 
 
Ageing of microglia occurs in a region-dependent manner  
Ageing is associated with altered inflammatory status systemically and in the brain 
and involves marked changes in microglial morphology and phenotype. However, it 
is unclear if the impact of ageing on microglia is uniform throughout the brain. We 
first determined if the gene networks defining young adult regional heterogeneity 
were equally sensitive to ageing. Overall, approximately 50% of region-defining 
transcripts at 4 months were differentially-regulated during ageing, however there 
was an unequal distribution across the major 4 month-old region-defining clusters of 
gene co-expression (see Fig 3). Notably, the majority (>80%) of transcripts from the 
4 month immune regulation cluster were age-regulated, but fewer than 25% of 
transcripts in the 4 month bioenergetics cluster were differentially expressed during 
ageing (Fig 7a) . This shows that distinct modules of co-ordinated gene transcription 
that define microglial heterogeneity in the young adult brain are differentially 
sensitive to ageing. 
Principal components analysis showed that while the gross relative regional 
relationship identified at 4 months was generally preserved during ageing, there was 
an age-dependent progression suggesting an interaction between age and brain 
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region (Fig 7b). First, cerebellar microglia were relatively more distant from the 
remaining brain regions at 12 and 22 months compared to 4 months. Second, the 
intermediate hippocampal microglia profile at 4 months was preserved at 12 months 
but largely converged with cortical and striatal samples at 22 months. We 
substantiated these observations non-subjectively using network analysis in 
Biolayout Express3D on the 13,741 transcripts regulated by age (FDR q < 0.05). 
Unbiased sample-to-sample correlation and clustering identified age-dependent 
unique cerebellar clusters and showed that hippocampal samples at 4 and 12 
months clustered independently whereas at 22 months they formed a larger cluster 
together with striatal and cortical samples (Fig 7c). These data show a region-
dependent influence on microglial ageing suggesting increased sensitivity of 
cerebellar microglia and a potential diminishing of the discrete hippocampal 
phenotype. 
The kinetics of microglial ageing were also region-specific. Changes in gene 
expression profile occurred relatively consistently during “early” (4-12 months) and 
“late” (12-22 months) ageing in both cerebellar and cortical microglia (Fig 7d). In 
contrast, changes were most pronounced during early ageing in the striatum and 
during late ageing in the hippocampus. The hippocampal pattern was particularly 
interesting because, in contrast to other regions where only ∼10% of gene alterations 
comprised decreased expression from 12 – 22 months, >30% declined in expression 
in hippocampal microglia (Fig 7e) supporting a diminishing distinction from other 
forebrain regions at the individual gene level. We also noted that twice the number of 
genes were differentially expressed (FDR q < 0.05, fold-change ≥ 1.5) at 22 versus 4 
months in cerebellar microglia compared to other regions further reinforcing their 
greater sensitivity to age-related change (Fig 7d). 
18 
 
Unsupervised hierarchical clustering and visualisation of age-region interacting 
genes (FDR q < 0.05) demonstrated a number of striking patterns (Fig 7f) likely 
underpinning the gross age-region relationships above. First, a large group of genes 
increased in expression during ageing in all regions, however, in the cerebellum this 
occurred earlier (i.e. by 12 months) and/or to a greater magnitude by 22 months. 
Second, there was a cluster of genes that increased during ageing only in the 
cerebellum. Third, expression of a group of genes initially detected at relatively 
greater levels in hippocampal and cerebellar microglia at 4 months declined during 
ageing selectively in the hippocampus.  
Collectively, these data show that the microglial transcriptome ages in a non-
uniform manner across brain regions. Key observations are an accelerated and more 
amplified ageing trajectory in cerebellar microglia and a declining distinction of the 
hippocampal phenotype (relative to other forebrain regions).  
 
Pathways underpinning region-specific microglial ageing profiles 
We next sought to establish the biological processes responsible for the age-region 
microglial interactions above. A correlation network graph of the age-regulated 
transcripts was clustered to non-subjectively sub-divide the graph into modules of 
highly co-expressed genes (Fig 8a). We focussed on clusters where interactions 
between age and region were most evident. In general, expression of cluster 2 
transcripts increased with age but the most striking features were the greater and/or 
earlier age-regulated increased expression in cerebellar microglia (Fig 8b). The 
majority of genes were involved in immunoregulatory function and this was 
supported by GO analysis showing immune-related processes as the most over-
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represented in cluster 2 (Supplementary Table 11). Multiple families of molecules 
were represented including those involved in sensing of self and foreign ligands, 
immune cell adhesion and chemotaxis, cytokine signalling and anti-microbial effector 
responses. A large group of co-expressed genes involved in several aspects of the 
interferon pathway was particularly prominent. This included transcriptional 
regulatory factors (e.g. Irf7, Stat2, Oasl1) and interferon-regulated genes including 
those encoding effector proteins involved in anti-viral defence (e.g. Sp100, Csprs, 
Isg20, Ifit families, Bst2, Zbp1). Expression of the above genes was not only 
increased to a significantly greater extent (e.g. 5-fold) during ageing in the 
cerebellum but increased expression was also evident earlier (12 months) (Fig 8c). 
Further genes involved in the interferon pathway predominantly increased in 
cerebellar microglia although not until 22 months (e.g. Stat1, Ifitm family, Gbp family) 
(Fig 8d). Genes more sensitive to greater and/or earlier age-related changes in 
cerebellar microglial included both those already more highly expressed in cerebellar 
microglia and those expressed at negligible levels in all regions at 4 months.  
Given the above data and regional differences in expression of ITAM and ITIM 
signalling immunoreceptors in microglia of young adult mice we assessed if there 
were region-dependent ageing responses of specific immunoreceptor families. There 
was a striking contrast in the ageing expression profile of amplifying and inhibitory 
immunoreceptors in all families examined (Fig 8e). Expression of inhibitory receptors 
from each family in general remained stable (e.g. Cd300a) or decreased in a largely 
region-independent manner (e.g. Cd200, Sirpa) during ageing. In contrast, 
expression of amplifying receptors increased with age and in a mostly region-
dependent manner, affecting the cerebellar microglia selectively (e.g. Cd300ld, 
Trem1, Sirpb1a) or to a significantly greater extent (e.g. Cd200r4, Cd300lb) than 
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other regions. The Cd300 family is presented as an example (Fig 8f) Thus, during 
ageing, alterations in immunoreceptor expression across multiple molecular families 
support a regionally-variable shift in balance towards immune amplification.  
Genes significantly decreased in expression (FDR q < 0.05, fold-change ≥ 1.5) 
from 4-22 months in hippocampal microglia showed enrichment of GO processes 
related to cell adhesion/migration/motility, membrane organisation/endocytosis, 
immune/inflammatory function, and vascular development (Supplementary Table 
12) suggestive of marked changes in the interaction of hippocampal microglia with 
their environment. Mining of these genes in the Biolayout Express3D network graph 
revealed their presence in several clusters each with a profile sharing reduced age-
related hippocampal expression. Cluster 14 was particularly interesting because it 
contained genes expressed at relatively greater levels in both hippocampal and 
cerebellar microglia at 4 months that selectively declined in the hippocampus (and in 
the striatum for a subset) during ageing (Fig 8g, h).  Among the genes in this cluster, 
many (e.g. Cd36, Cd93, Pf4, Lyve1) are involved in cell adhesion and motility 
pathways through interactions with matrix components and other extracellular 
ligands (Fig 8h). Consistent with the above functions, genes co-ordinating cross-
regulation of endocytosis/phagocytosis and cytoskeletal reorganisation were present, 
notably Arhgef3, Dab2, Itsn1 and Vav3. Some of the above genes have overlapping 
roles in immune function through sensing and internalisation of microbial ligands and 
involvement in antigen processing and presentation (e.g. Cd36, Cd93, Pf4). 
Together with further genes in this cluster such as the mannose receptor gene Mrc1 
and the MHC-II genes H2-Aa and H2-Ab1 (Fig 8h) it was evident that gene networks 
involved in certain aspects of ligand recognition, processing and presentation are 
relatively selectively suppressed during ageing in hippocampal microglia. More 
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generally, the above data support a potential “disengagement” of aged hippocampal 
microglia with their environment compared to their young adult counterparts.   
 
Regionally-variable depression of the “homeostatic” microglial signature 
during ageing  
Microglial heterogeneity in the young adult brain was superimposed upon a core 
signature distinguishing microglia from systemic macrophages. Ageing resulted in a 
modest decline in expression across all forebrain regions of key signature genes and 
a significantly greater effect (e.g. 30% reduction in expression from 4 to 22 months 
old) in cerebellar microglia (e.g. Tmem119, P2ry12, P2ry13, Fcrls) (Supplementary 
Fig 6a). This supports data above that the greatest deviation from the “baseline” 
young adult homeostatic signature during ageing occurs in cerebellar microglia. 
Reduced expression of TGFβ receptor genes in aged microglia (Supplementary Fig 
6b)  may be important because expression of signature-defining genes is regulated 
by TGFβ12. In contrast, signature macrophage genes (e.g. Serpinb2, Alox15, Fabp4) 
were expressed at negligible levels at all ages (Supplementary Fig 6c)  and genes 
commonly expressed on macrophages and microglia and upregulated on overtly 
activated microglia (e.g. Ptprc, Emr1) and Itgam were stably expressed during 
ageing in all regions (Supplementary Fig 6d). These data suggest that the age-
related lessening of the young homeostatic microglial signature is regionally variable 






The data presented here provide compelling evidence of regional microglial 
phenotypic diversity in the healthy adult brain and the region-dependent impact of 
ageing on microglial phenotype. To our knowledge, this is the first demonstration that 
regional localisation of microglia influences their genome-wide expression profile 
across the adult lifespan, and notably we show that this extends beyond their 
immunophenotype. Key findings include that (1) transcriptional networks controlling 
microglial bioenergetic and immunoregulatory functions contribute prominently  to 
heterogeneity in the young adult, (2) immunophenotypic variation suggests a more 
immune vigilant state of cerebellar microglia, (3) networks of gene co-expression 
underpinning heterogeneity in the young adult brain are differentially sensitive to 
ageing, (4) increasing distinction of cerebellar microglia and reduced distinction of 
hippocampal microglia (among forebrain regions) are key features of ageing, (5) 
microglial diversity is superimposed upon a core profile that distinguishes all 
microglia from macrophages, and (6) aged microglia display partial loss of the core 
young adult microglial identity in a regionally-variant manner but do not adopt a 
macrophage-like signature.  
In the young adult brain (4 months old), the general relationship among the brain 
regions analysed showed that cerebellar microglia were most distinct, that cortical 
and striatal microglia were similar to each other, and that hippocampal microglia had 
an intermediate profile. This pattern suggests a microglial relatedness correlating 
with the relative positioning of brain regions along the rostro-caudal neuroaxis. 
Recent studies have reported that microglial responses to injury, disease or 
inflammatory challenge also vary according to neuroaxis location36, 37. Microglial 
morphology and density vary according to the relative composition of white and grey 
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matter with a lower density of microglia reported in white matter of the adult mouse 
brain13. The extent to which white-to-grey matter ratios could influence regional 
differences in microglial transcriptomes is unclear, although the finding that the white 
matter-rich striatum and largely grey matter-dominant cerebral cortex have highly 
similar expression profiles suggests this may not be a major determinant. Forebrain 
microglia but not cerebellar microglia are dependent on IL-34, a ligand of the colony 
stimulating factor-1 receptor, for their maintenance15, 16. Furthermore, the 
involvement of enhancers in controlling tissue and cell identity is increasingly 
recognised, including in microglia38, and a recent study indicated that expression of 
brain region-specific enhancer RNAs may play a particularly important role in 
cerebellum-specific gene expression18.  
Heterogeneity in microglial phenotypic markers other than immunophenotype 
has received negligible attention previously. The present data provide novel 
information on the transcriptional programmes controlling metabolism in microglia 
and show that regional differences in expression of these networks is a core feature 
of microglial diversity in the healthy young adult brain. Co-ordinated differences in 
regional expression of genes involved in all phases of the energy production 
pathway (mitochondrial production, glycolysis, TCA cycle, electron transport chain, 
ATP synthesis) was evident, emphasising the integrated nature of regional 
bioenergetic variation in microglia. The cluster profile revealed that hippocampal and 
cerebellar microglia have relatively greater expression of these genes suggesting 
greater energetic demands on microglia in these areas. Although there is little 
understanding of microglial bioenergetics, the routine cellular behaviour of microglia 
(e.g. process scanning, phagocytic activity) is likely to be metabolically demanding 
and regional differences in these activities could therefore influence energy 
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demands39. In addition, the lower density of microglia in some areas, notably in the 
cerebellum, requires each microglial cell to survey a larger volume of tissue and 
would be expected to increase energy demands on an individual cell basis.  
 Our data suggest that microglia in some regions of the young adult brain exist in 
a more immune-vigilant state but one that does not equate to a conventional 
activated or primed microlgial/macrophage phenotype. Local differences in the 
physical and neurochemical environment, such as cellular and matrix composition, 
blood-brain barrier permeability, neurotransmitter profiles and heterogeneity in other 
cell types, may all be important. Consistent with this we found that a substantial 
proportion of genes encoding the microglial-enriched cell surface sensing apparatus 
were differentially expressed. Previous studies have suggested white matter 
microglia exist in a relatively less quiescent basal state than their grey matter 
counterparts37, which could contribute to the more vigilant profile of microglia in the 
white matter-enriched cerebellum. Another explanation is that the environment of 
some brain regions has evolved to support a more immune vigilant phenotype as a 
result of genomic integration of endogenous retroviruses (ERVs) and other 
retrotransposons. ERVs comprise ~10% of the murine genome40 and although 
normally inactive, deficiencies in innate immunity can predispose to reactivation41. 
Cerebellum-specific expression of the murine leukaemia virus (MuLV)-ERV has been 
shown previously42 and in mixed brain homogenates expression of the MuLV-ERV 
designated Mela (melanoma antigen) was restricted to the cerebellum 
(Supplementary Fig 7). The hippocampus is also more susceptible to 
retrotransposition in the human brain43. Thus, microglia, which we show have a more 
immune vigilant phenotype, including higher expression of anti-viral interferon 
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networks, are found in areas where there may have been an evolutionary drive for 
development of greater immune vigilance.   
Despite sharing similarities in their regional expression profile in the young adult 
brain, the major transcriptional networks (bioenergetics and immune) underlying 
regional heterogeneity at 4 months of age were affected differently by ageing. Genes 
within the immune networks were particularly sensitive whereas the majority within 
the bioenergetics cluster were unaffected by age. This indicates that regional 
differences are preserved during ageing for some functional pathways alongside 
marked divergence in others. Given the similar regional profiles of the immune and 
bioenergetics clusters at 4 months of age and the close relationship between 
immune function and metabolism, there may be some degree of immune-metabolic 
decoupling during ageing particularly in microglia from regions showing the greatest 
immunoregulatory deviation from the young adult (e.g. cerebellum). However, further 
work will be needed to determine if this divergence could allow for greater adaptation 
to the demands of ageing or could predispose to functional dysregulation.  
The sensitivity of the immune network to ageing was largely responsible for the 
increasing distinction of the cerebellar phenotype in the aged brain. In contrast to 
ageing and direct immune stimulation ex vivo, however, we observed regionally 
comparable responses to acute systemic inflammatory challenge with bacterial 
lipopolysaccharide (data not shown) indicating that microglial heterogeneity encodes 
region-specific sensitivities in a stimulus/stressor-dependent manner. A selective or 
significantly greater induction in expression of many immune amplifying genes 
occurred in cerebellar microglia compared to other brain regions during ageing 
whereas genes involved in restraining excessive immune activity were generally 
stable across all brain regions. This implies that the more immune alert state of 
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cerebellar microglia compared to other regions evident in the young adult is further 
augmented in the aged brain. The functional consequences of this are important to 
consider but may be complex. More caudal regions of the CNS such as the 
cerebellum may be more vulnerable to age- or disease-related inflammatory 
degeneration if this heightened alertness is poorly controlled. In support, age-related 
increases in inflammatory marker expression were predominant in the cerebellum 
and associated with functional cerebellar deficits37. However, the extra-alert 
phenotype may confer protective functions through increased vigilance and 
efficiency in removing potentially harmful agents. In this regard, it is pertinent to note 
the lower susceptibility of the cerebellum to amyloid deposition during ageing44.  
Selective age-related alterations in gene networks were also evident in 
hippocampal microglia, however in contrast to the cerebellum, these resulted in a 
declining distinction from other forebrain regions. Decreasing expression of genes 
involved in matrix interactions and sampling the extracellular environment were the 
most prominent cause, suggesting that a declining engagement with their 
environment during ageing particularly affects hippocampal microglia. Although 
previous studies were not performed on a region-specific basis our data are 
consistent with reports of decreased process motility45 and reduced expression of 
cell surface sensing genes11 in aged microglia indicative of compromised 
environmental sampling capabilities. In contrast to the cerebellum, the hippocampus 
is vulnerable to age- and disease-related deposition of misfolded proteins which 
could in part relate to the age-driven divergence in environmental and immune 
alertness of microglia we describe in these brain regions. Dystrophic microglia in the 
aged human hippocampus have been described and postulated to represent a 
senescent state unable to carry out normal functions46; our data may provide a 
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plausible transcriptomic basis for this hypothesis. More broadly, the loss of 
distinction in the overall hippocampal microglial phenotype at 22 compared to 4 
months of age among forebrain regions is consistent with the concept of age-related 
loss of differentiation in neural function, cognitive performance and reorganisation of 
connectivity across brain regions47, 48. Notably, the weighting of regional connections 
of the hippocampus changes markedly during ageing48. Declining specialisation 
among neuronal populations has also been described in the aged brain49. It is 
therefore possible that age-related changes in the regional diversity of local signals 
derived from other neural components, altered inter-regional communication, and 
intrinsic microglial modifications in sensing pathways could all contribute to the 
diminished regional identity of hippocampal microglial in the aged brain. 
Recent studies have revealed the distinctive transcriptional identity of microglia 
that distinguishes them from non-CNS tissue macrophages11, 12, 19. The present data 
now show that, although microglia have multiple transcriptional identities dependent 
on brain region, a core signature differentiating them from macrophages is retained 
across regions. Hence inter-regional microglial heterogeneity is superimposed upon 
a distinctive core profile. Microglial regional heterogeneity may be analogous in 
some respects to macrophage diversity observed within other tissues such as the 
spleen50. Despite reductions in expression of signature microglial genes with age, 
particularly in the cerebellum, highly macrophage-enriched genes (e.g. Fabp4, 
Alox15) were not expressed in any region at any age thus supporting that microglia 
also retain an overriding phenotypic individuality compared to macrophages in the 
aged brain.  
In summary, regional microglial diversity described herein may be important for 
meeting the location-dependent demands of brain tissue under steady-state 
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conditions. The impact of ageing on this diversity also suggests a basis for the 
regional variation in susceptibility to age-related neurodegenerative processes 
involving neuroinflammatory mechanisms. Further studies examining microglial 






Microarray data are deposited in the NCBI GeoDatasets database with the 
accession number GSE62420. 
 
Mice  
Experiments were performed using male C57Bl/6J mice (Charles River Laboratories, 
UK) and Csf1r-EGFP reporter mice bred in-house. Mice were housed in individually-
ventilated cages (five mice per cage) maintained under specific pathogen-free 
conditions and a standard 12 h light/dark cycle with unrestricted access to food and 
water. All experiments using live animals were conducted under the authority of UK 
Home Office project and personal licences and adhered to regulations specified in 
the Animals (Scientific Procedures) Act (1986) and Directive 2010/63/EU and were 
approved by both The Roslin Institute’s and the University of Edinburgh’s Animal 
Welfare and Ethics Committees.  
 
Microglial purification and mixed brain cell/homogenate preparation 
At 4, 12 and 22 months of age, mice were perfused transcardially with physiological 
saline and brains dissected into cerebellum, cortex, hippocampus and striatum. 
Tissue from eight mice was pooled for each regional replicate to obtain sufficient 
RNA for microarrays and the experiment was performed in quadruplicate for each 
region. Brain tissue was finely minced by scalpel blade in ice-cold Hanks Balanced 
Salt Solution HBSS (Sigma, UK), centrifuged (400 g, 5 min, 4°C) then resuspended 
and incubated for 1 h at 37°C using an enzyme cocktail containing 50U/ml 
collagenase, 8.5 U/ml dispase, 100 ug/ml Nα-Tosyl-L-lysine chloromethyl ketone 
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hydrochloride and 5 U/ml DNaseI in 9.64 ml HBSS (Life Technologies, UK). Tissue 
was dissociated manually using a Dounce homogeniser and the enzymatic reaction 
terminated by addition of equal volume HBSS containing 10% fetal bovine serum. 
Homogenates were centrifuged (400 g, 5 min, 4°C) and pellets resuspended in 35% 
Percoll (GE Healthcare, Sweden), overlaid with HBSS then centrifuged (800 g, 45 
min, 4°C). The supernatant and myelin layers were discarded and the cell pellet 
enriched with microglia resuspended in separation buffer (0.5% bovine serum 
albumin, 2 mM EDTA in PBS). The cell suspension was incubated with anti-CD11b 
microbeads (Miltenyi Biotec, UK) for 15 min at 4°C then applied to a magnetic LS 
column (Miltenyi Biotec) and cells retained on the column (microglia) were flushed 
and resuspended in appropriate buffer for downstream applications (see below). 
Unretained cells were also collected during initial validation for comparison. Mixed 
brain cell suspensions were prepared for flow cytometry according to the above 
protocol except the procedure was terminated before proceeding to centrifugation on 
Percoll gradient. For preparation of regional brain tissue homogenates for RNA 
extraction, mice were perfused and brain tissue dissected as above, and tissue 
snap-frozen and stored at -80°C. For validating that regional brain dissection did not 
result in cross-contamination of brain regions, the expression profile of established 
regionally enriched neuronal genes (Calb2, cerebellum-enriched; Rorb, cerebral 
cortex-enriched; Drd1a, striatum-enriched; Sstr4, hippocampus-enriched) was 
assessed in the present regional brain homogenates.  This showed the expected 
enrichment of Calb2 in cerebellum, Rorb in cerebral cortex, Sstr4 in hippocampus, 
and Drd1 in striatum and was comparable to the regional pattern reported in the 
Allen Brain Atlas51 (http://mouse.brain-map.org/) (Supplementary Fig 1d). URLs for 
images shown in Supplementary Fig 1 are: Calb2, http://mouse.brain-
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map.org/experiment/show/79556662 (image 78); Drd1a, http://mouse.brain-
map.org/experiment/show/352 (image 293); Rorb: http://mouse.brain-
map.org/experiment/show/79360296 (image 61); Sstr4: http://mouse.brain-
map.org/experiment/show/73636037 (image 234). 
 
Flow cytometry 
For routine verification of purified samples, cells resuspended in FACS buffer (0.1% 
BSA in PBS) were incubated with 1μg/ml anti-CD16/CD32 (Biolegend, UK, cat # 
101301) to block Fc receptors and stained with anti-mouse CD11b-PE (Biolegend, 
cat # 101207, clone: M1/70), CD45-Pacific Blue (Biolegend, cat # 103125, clone: 30-
F11) and F4/80-APC (Biolegend, cat # 123115, clone: BM8). To assess overlap 
between microglial CD11b and EGFP expression in mixed brain cell suspensions 
from Csf1r-EGFP mice, samples were stained as above and microglia identified 
according to their characteristic CD11b+F4/80+CD45lo profile. To measure MHC-II 
expression on microglia from mixed brain cell suspensions, cells were stained with 
RPE-Alexa Fluor 750 anti-mouse CD11b (AbD Serotec UK, cat # MCA74P750T), 
APC anti-mouse CD45 (Biolegend, cat # 103111) and eFluor 450 anti-mouse MHC 
Class II (eBioscience, UK, cat # 48-5321-80). Flow cytometry was performed using a 
FACS Aria IIIu or LSR Fortessa (Becton Dickenson, UK) and data analysed using 
FlowJo software (FlowJo, OR, USA). 
 
Microglial culture and immunocytochemistry 
1 x 105 purified microglial cells were cultured for 7 d in an 8-well chambered 
coverslip μ-slide (Ibidi, Germany) with DMEM/F12 (Life Technologies, UK) containing 
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10% FBS and 1% penicillin/streptomycin before fixation with 4% paraformaldehyde. 
The staining procedure was performed at room temperature. Fixed cells were 
permeabilised with 0.1% Triton X-100 for 5 min, washed and quenched by adding 
0.25% NH4Cl for 5 min. Permeabilised cells were washed and blocked in PBS/0.1% 
BSA/5% donkey serum (Jackson ImmunoResearch, PA,USA) for 1 h before adding 
the primary antibodies prepared in 2.5% donkey serum in PBS. We used the 
following primary antibodies for staining: rabbit anti-IBA-1 (Wako Chemicals, 
Germany; 1:200) and biotinylated anti-mouse F4/80 (eBioscience, 1:200). Cells were 
washed and secondary antibodies anti-rabbit Alexa Fluor 594 (Life Technologies 
1:1000) and Streptavidin Alexa Fluor 488 (Life Technologies; 1:1000) were 
incubated for 1 h before counter staining with DAPI (1µM) for 5 min. Imaging was 
performed using a Zeiss LSM 710 inverted confocal microscope. Maximum 
projection images of Z-stacks at 400x magnification objectives are presented. 
 
RNA extraction 
Microglia purified from individual brain regions were immediately processed for RNA 
extraction using the RNeasy Plus Micro Kit (Qiagen, UK). Preliminary experiments 
showed this method produced the highest yield and quality of RNA. RNA was 
extracted according to the manufacturer’s instructions with the exception of the final 
step where RNA elution was repeated twice with 10 µl RNase-free water. RNA 
quantities were determined by Nanodrop 1000 (Thermo Fisher Scientific, MA, USA) 
and RNA quality assessed using the Agilent Bioanalyzer (Agilent Technologies, CA, 
USA). RNA was also extracted from regional mixed brain cell homogenates using 
33 
 
the RNeasy Midi Kit (Qiagen) following manufacturer’s instructions. All samples 
passed a quality control threshold (RIN ≥ 8) to proceed to microarray. 
 
Transcriptional profiling using gene expression microarrays 
Microarray assays were performed by Edinburgh Genomics, University of Edinburgh 
(https://genomics.ed.ac.uk/). Total RNA was labelled using the IVT Express Kit 
(Affymetrix). First-strand cDNA was synthesised and converted to double-stranded 
DNA template for transcription and synthesis of aRNA incorporating a biotin-
conjugated nucleotide. aRNA was purified and fragmented prior to hybridisation on 
Affymetrix arrays. Biotin-labelled aRNA was hybridized to the whole mouse genome 
HT MG-430 PM array plate (Affymetrix, CA, USA) representing >39,000 transcripts, 
using the GeneTitan multi-channel instrument (Affymetrix). 
 
qPCR 
50ng of total RNA remaining from the microarray samples was reverse transcribed 
using Superscript III Reverse Transcriptase according to the manufacturer’s 
instructions (Life Technologies). The qPCR was performed in a Stratagene Mx3005P  
instrument (Agilent Technologies) using Platinum SYBR Green qPCR SuperMix-
UDG (Invitrogen) and primer pairs: B2m-f TGGCTCACACTGAATTCACCCCCA 
B2m-r TCTCGATCCCAGTAGACGGTCTTGG, Gapdh-f 
TGCATCCACTGGTGCTGCCAA, Gapdh-r ACTTGGCAGGTTTCTCCAGGCG, 
Camp-f AGGAACAGGGGGTGGTGA, Camp-r CACCTTTGCGGAGAAGTCCA, H2-
d1-f TCCGAGATTGTAAAGCGTGAAGA, H2-d1-r GAACCCAAGCTCACAGGGAA. 
qPCR cycles were performed as followed: hot start denaturation cycle 95°C for 10 
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min, 40 cycles of amplification of 95°C for 15 sec, 60°C for 20sec and 72°C for 1 
min.  
 
Bacterial phagocytosis and replication assay 
Purified cortical and cerebellar microglia (pooled from 8 mice, 4 months old) were 
infected with Escherichia coli (K-12 strain). Bacteria were grown in Luria-Bertani (LB) 
broth at 37°C, 190 rpm for 16 hours. Subsequently bacteria were subcultured at 
1:1000 ratio into fresh LB. Bacteria were grown to mid-exponential phase at 37°C, 
190 rpm for 3 hours and growth was monitored at OD600. Bacteria were 
resuspended in DMEM/F12 (no FBS/Penicillin/Streptomycin) at 1 x 107 bacteria/ml. 4 
x 104 purified microglia were infected with 4 x 105 bacteria. 4 x 104 cells only and 4 x 
105 bacteria only served as control. After incubation of microglia with bacteria for 2 
hours to allow uptake, gentamicin was added to kill extracellular bacteria, enabling 
intracellular E. coli to be enumerated 1 and 4 hours later. Cells were then washed, 
lysed with 0.1% Triton X-100 and serial ten-fold dilutions plated on MacConkey agar. 
Bacterial colonies were counted after 17 h incubation at 37°C. Data are from 
triplicate microglial samples with each replicate pooled from eight mice. The 
microglia only control yielded no bacteria and extracellular E. coli treated with 
gentamicin under the same assay conditions was completed eliminated.  
 
Computational analysis and bioinformatics 
(i) Analysis of regional heterogeneity in the young adult (4 months old) 
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Microarray datasets were normalised by the Robust Multiarray Averaging (RMA) 
method in Affymetrix Expression Console (Affymetrix, CA, USA) prior to analysis in 
BioLayout Express3D (http://www.biolayout.org/)20 or directly during import for 
analysis in Partek Genomics Suite (Partek Inc., MO, USA. Analysis was perfomed 
using the ht_mg-430_pm.na33 annotation release (Affymetrix). 4 months datasets 
were first normalised and analysed independently from other ages.  The gross inter-
relationships among regional microglial transcriptomes were assessed by principal 
components analysis (PCA) on the log-transformed and Z-score transformed data 
matrix where every transcript had mean value zero and standard deviation one, 
using built-in functions of Matlab (MathWorks, MA, USA). Gross regional differences 
were also assessed in BioLayout Express3D by plotting a sample-to-sample 
correlation graph with the Pearson correlation threshold r = 0.96. Nodes represent 
individual samples (replicates) and edges between them show correlation of 
expression pattern with Pearson correlation coefficients above the selected 
threshold. The resulting network was clustered using the Markov clustering algorithm 
(MCL) (inflation 2.2) to non-subjectively sub-divide the graph into discrete clusters.  
To assess if there were transcripts differentially expressed by region overall and 
between each individual region, normalised datasets were compared in Partek by 
ANOVA with false discovery rate (FDR) correction (q < 0.05). Data were visualised 
by heatmap with transcripts and samples organised by hierarchical clustering using 
average linkage with the Euclidean distance metric. Heatmap visualization and 
hierarchical clustering were performed on the log-transformed and Z-score 
transformed data matrix using built-in functions of Matlab. To assess gene co-
expression relationships across brain regions, a pairwise transcript-to-transcript 
matrix was calculated in BioLayout Express3D from the set of regionally differentially 
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expressed transcripts using a Pearson correlation threshold r = 0.80. A network 
graph was generated where nodes represent individual probesets (transcripts/genes) 
and edges between them correlation of expression pattern with Pearson correlation 
coefficients above the selected threshold. The graph was clustered into discrete 
groups of transcripts sharing similar expression profiles using the MCL algorithm 
(inflation 2.2, minimum cluster size 10 nodes). The composition and functional 
representation of the three major clusters were explored in more detail.  
Enrichment analysis for Gene Ontology (GO) terms was performed in DAVID52 
(http://david.abcc.ncifcrf.gov/) and visualised using the Enrichment Map plugin 
(http://www.baderlab.org/Software/EnrichmentMap)53 for Cytoscape 
(http://www.cytoscape.org/)54. In DAVID, gene lists were uploaded and the 
GOTERM_BP_FAT annotation category selected. Default settings were used for 
analysis with enrichment based on p < 0.05 with Benjamini correction. Enriched GO 
terms were uploaded to Enrichment Map and a network graph constructed.  Nodes 
represent enriched GO terms and edges the degree of similarity between them using 
the overlap coefficient. Enrichment Map was also used to visualise the expression of 
all genes in the regionally differentially expressed dataset annotated with GO terms 
within the immune regulation cluster (Fig 2d).  Results were visualised by heatmap 
with expression values normalised and transcripts organised by hierarchical 
clustering using default settings (Supplementary Fig 5). Visualisation of GO 
enrichment was also performed using the GOrilla tool55 (http://cbl-
gorilla.cs.technion.ac.il/) with default settings applied. Pathway analysis on individual 
clusters from the BioLayout Express3D transcript-to-transcript network graph was 
performed in DAVID using the KEGG tool and Ingenuity Pathway Analysis (Qiagen). 
37 
 
To compare immunophenotypes in the present dataset with microglial activation 
profiles described previously, we mined published microarray datasets from 
microglia stimulated with either lipopolysaccharide (LPS) or interleukin-4 (IL-4)25. 
Raw expression data (.cel files) were downloaded from NCBI GEO DataSets 
(http://www.ncbi.nlm.nih.gov/gds/;GSE49329), imported to Partek and normalised 
with the microglia data. Non-overlapping genes significantly upregulated by LPS or 
IL-4 (>5-fold, FDR q < 0.05) were determined and these genes overlaid on the set of 
regional differentially expressed genes from the present study. The expression 
profile of overlapping transcripts for each stimulus was visualised by heat map using 
the log-transformed and Z-score transformed data matrix using built-in functions of 
Matlab. 
To analyse a specific subset of microglial-enriched genes encoding cell surface 
proteins we assessed overlap between the 100 genes recently described as the 
microglial sensome and the set of regionally differentially expressed genes from the 
present study. The expression profile of overlapping transcripts was visualised by 
heat map using the log-transformed and Z-score transformed data matrix using built-
in functions of Matlab.  
To assess the extent of microglial regional heterogeneity in the context of 
general tissue macrophage diversity, we mined published peritoneal and bone 
marrow macrophage microarray datasets from the GNF MouseAtlas V3 (GEO 
DataSets GSE10246) which were generated on the same platform (MOE430 2.0) as 
the present arrays. All datasets were imported together and normalised in Partek as 
above. The gross relationships among microglia and macrophages were explored by 
PCA. Genes most highly expressed in microglia compared to macrophages (>10-
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fold, q < 0.05) were determined for each brain region and overlapping and unique 
genes among regions identified. 
For the identification of transcriptional regulators which may act as contributing 
factors to the microglial regional diversity we used Clover27 to detect statistical over-
representation of known TFB motifs in the promoter regions of co-expressed genes. 
Refseq IDs for each transcript on the Affymetrix ht_mg-430_pm.na33 array that was 
present in the immune regulatory and energy metabolism cluster were obtained from 
the NetAffx database (https://www.affymetrix.com/analysis/netaffx/index.affx). 
Promoter sequences 300bp upstream and 100bp downstream of the TSS were 
extracted from the mouse genome sequence (version mm9). Transcription factor 
binding site motifs were identified using the JASPAR CORE motif set26 
(http://jaspar.cgb.ki.se) and Clover (p < 0.05, score threshold = 6) was used to detect 
over-represented motifs in promoters for each expression cluster compared with a 
background set27.  
 
(ii) Effect of ageing and analysis of interactions between ageing and brain region 
Analysis was performed on datasets from all ages normalised together and 
performed as above. Gross inter-relationships among regional microglial 
transcriptomes at different ages (4, 12, 22 months of age) were assessed by PCA as 
above and in BioLayout Express3D. For BioLayout Express3D, a sample-to-sample 
correlation network graph (Pearson correlation threshold r = 0.98) was generated 
from the transcripts differentially expressed according to age (FDR q < 0.05) and 
clustered using the MCL algorithm (inflation 2.2) to non-subjectively sub-divide the 
graph into discrete clusters. Nodes represent individual samples (replicates) and 
39 
 
edges between them show correlation of expression pattern with Pearson correlation 
coefficients above the selected threshold. To determine effects of ageing and 
interactions between ageing and brain region on individual transcript expression, 
normalised datasets were analysed in Partek Genomics Suite using two-way 
ANOVA with FDR correction (q < 0.05) and appropriate post-hoc tests as indicated. 
Hierarchical clustering and visualisation of the top 150 transcripts with significant 
interaction between age and region on expression levels was performed in Partek.  
Transcript-to-transcript co-expression relationships were assessed using 
BioLayout Express3D. A pairwise transcript-to-transcript matrix was calculated from 
the set of transcripts differentially expressed according to age using a Pearson 
correlation threshold r = 0.85. A network graph was generated where nodes 
represent individual probesets (transcripts/genes) and edges between them 
correlation of expression pattern with Pearson correlation coefficients above the 
selected threshold. The graph was clustered non-subjectively into discrete groups of 
transcripts sharing similar expression profiles using the MCL algorithm (inflation 2.2, 
minimum cluster size 10 nodes). The composition and functional representation of 
selected clusters were explored in more detail using approaches as above (e.g. GO 
and KEGG enrichment analysis).  
Relative expression profiles of genes from selected immunoreceptor families were 
visualised by heat map using the log-transformed and Z-score transformed data 
matrix using built-in functions of Matlab. Genes were classified as activating or 
inhibitory according to known functional effects or prediction from presence of 




Experimental design and statistical analysis 
Experimental design, analysis and reporting followed the ARRIVE guidelines 
(https://www.nc3rs.org.uk/arrive-guidelines) where possible. Mice were randomised 
to treatment group (age) at cage level using using a computer-based random 
number generator (https://www.randomizer.org/).  Microarray data are from n = 4 
biological replicates with each replicate consisting of tissue pooled from 8 mice. No 
formal a priori statistical methods were used to pre-determine sample sizes due to 
insufficient previous data to enable this. However, sample sizes were chosen based 
on estimates of anticipated variability through previous general experience of 
microarray analysis and accounting for pooling of tissues reducing inter-replicate 
variance. To avoid potential confounding cage effects during pooling of tissue, each 
separate pool contained tissue derived from mice housed in all cages for each age 
group selected in a randomised manner using a computer-based random number 
generator (https://www.randomizer.org/). Data collection and analysis were 
performed with the assessor unaware of allocation to treatment group. Statistical 
tests for computational analysis are described above. Flow cytometry and qPCR 
data were analysed using one-way ANOVA with Bonferroni correction. Data from the 
bacterial uptake and replication assay were analysed by two-way ANOVA with 
Bonferroni correction. Data were checked for compliance with statistical assumptions 
for each test, including normal distribution and equal variances across groups. Tests 
were two-tailed throughout. Statistical significance was considered at p < 0.05 (or 
equivalent corrected for multiple comparisons). Data show mean ± SD unless 
otherwise stated. 
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Figure 1. Validation of multi-region microglial purification. (a) Microglia were purified 
from discrete brain regions and the profile of expression for indicated surface 
markers examined by flow cytometry. A consistent CD11b+F4/80+CD45lo profile was 
observed for all regions (Con denotes isotype control staining of whole brain 
microglia). Data are representative of four independent cell preparations, each from 
tissue pooled from eight mice. (b) Microarray expression profiles for selected genes 
in purified microglia and mixed brain cell homogenates from each brain region. Data 
show mean ± SD, n = 4 independent samples, each from tissue pooled from eight 
mice (c) The fold change (log2) in microarray expression level for purified microglia 
versus mixed cell brain homogenates for indicated genes. (d) Microarray expression 
profiles in purified microglia from discrete brain regions for established marker genes 
of neurons, astrocytes and oligodendrocytes, (e) T cells (Cd3e), B cells (Cd19), 
granulocytes (Ly6g), and (f) non-CNS macrophages with comparison to Itgam. Data 
show mean ± SD, n = 4 independent samples, each from tissue pooled from eight 
mice. (g) Immunofluorescence images of purified microglia cultured for 7d and 
immunostained for indicated markers. Images are representative of two independent 
cultures. Scale bar, 50μm. Str, striatum; Hpp, hippocampus; Ctx, cerebral cortex; 
Cbm, cerebellum. 
 
Figure 2. The adult mouse microglial transcriptome is regionally heterogeneous. (a) 
Principal components analysis on microarray expression profiles for purified 
microglia from discrete brain regions. (b) Sample-to-sample correlation of microarray 
datasets was performed in BioLayout Express3D and a network graph generated 
(Pearson correlation threshold r ≥ 0.96). Nodes represent individual samples and 
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edges the degree of correlation between them. (c) Heat map showing the expression 
pattern of probesets differentially expressed by brain region (p < 0.05 with FDR 
correction). The scaled expression value (row Z-score) is displayed in a blue-red 
colour scheme with red indicating high expression and blue low expression. (d) 
Differentially expressed probesets were analysed for enrichment of Gene Ontology 
(GO) Biological Processes in DAVID. Enriched GO terms were imported to 
Enrichment Map and a network graph generated. Nodes represent individual GO 
terms (gene sets) and edges the relatedness between them. Two major clusters 
defined by immunoregulatory and metabolic function were identified. Str, striatum; 
Hpp, hippocampus; Ctx, cerebral cortex; Cbm, cerebellum. 
 
Figure 3. Three major patterns of gene co-expression underpin regional microglial 
transcriptional heterogeneity. (a) A transcript-to-transcript correlation network graph 
of transcripts significantly differentially expressed by brain region was generated in 
BioLayout Express3D (Pearson correlation threshold r ≥ 0.80). Nodes represent 
transcripts (probesets) and edges the degree of correlation in expression pattern 
between them. The network graph was clustered using a Markov clustering algorithm 
and transcripts assigned a colour according to cluster membership. Three major 
clusters were identified. (b) Mean expression profile of all transcripts within clusters 
1, 2 and 3. (c) Heat maps showing the expression profile of all transcripts contained 
within clusters 1, 2 and 3. Each probeset is represented in a blue-red row Z-score 
scale with red indicating high expression and blue low expression. Str, striatum; Hpp, 




Figure 4. Regional transcriptional heterogeneity in microglial immunophenotype and 
bioenergetics. (a) Cluster 3 transcripts were analysed for enrichment of Gene 
Ontology (GO) Biological Processes in DAVID (p < 0.05 with Benjamini correction) 
and a network graph of enriched GO terms generated in Enrichment Map. Nodes 
represent individual GO terms (gene sets) and edges the relatedness between them. 
(b) Examples of individual genes in cluster 3 manually annotated to functional 
categories of immunoregulatory function. (c) mRNA expression of selected genes in 
purified microglia measured by quantitative PCR. Data show mean ± SD, n = 4 
independent samples, each from tissue pooled from eight mice. *p < 0.05, **p < 
0.01, ***p < 0.001, one-way ANOVA with Bonferroni correction. (d, e) Expression of 
MHC-II protein was measured by flow cytometry on freshly isolated adult microglia 
identified by CD11b+CD45lo profile in mixed brain cell suspensions from discrete 
brain regions. Data show (d) proportion of CD11b+CD45lo microglia positive for MHC-
II and (e) mean fluorescence intensity of MHC-II expression on CD11b+CD45lo cells. 
Data show mean ± SD, n = 3 independent cell preparations. ***p < 0.001, one-way 
ANOVA with Bonferroni correction. (f) Cluster 2 transcripts were analysed for 
enrichment of GO Biological Processes (p < 0.05 with Benjamini correction) and a 
network graph of enriched GO terms generated in Enrichment Map. (g, h) Examples 
of individual genes in cluster 2 manually annotated to functional categories of 
bioenergetic function.  Data show mean ± SD, n = 4 independent samples, each 
from tissue pooled from eight mice. *p < 0.05, **p < 0.01, ***p < 0.001, one-way 
ANOVA with Bonferroni correction. Str, striatum; Hpp, hippocampus; Ctx, cerebral 
cortex; Cbm, cerebellum. Specific p values for all statistical comparisons are 




Figure 5. Regional microglial heterogeneity in immunophenotype suggests 
differences in immune vigilance. (a) Microarray expression levels in purified microglia 
of selected families of immunoreceptors containing activating and inhibitory 
members. Data show mean ± SD, n = 4 independent samples, each from tissue 
pooled from eight mice. *p < 0.05, **p < 0.01, ***p < 0.001, one-way ANOVA with 
Bonferroni correction. (b,c) Heat maps showing microarray expression patterns of 
immunoreceptor genes arranged according to (b) family and (c) activating (A) or 
inhibitory (I) status. Column Z-score intensities represent the mean of four 
independent samples per region with red referring to a high probeset expression and 
blue low expression (d) Genes uniquely induced (>5-fold, p < 0.05 with FDR 
correction) by LPS or IL-4 in microglia were determined from publicly available 
microarray expression datasets25. (e,f) Heat maps showing microarray expression 
patterns for the subsets of unique (e) LPS- or (f) IL-4-inducible genes that were 
differentially expressed (p < 0.05 with FDR correction) according to brain region. 
Row Z-score intensities represent the mean of four independent samples per region 
with red referring to a high probeset expression and blue low expression. (g) 
Microarray expression levels of archetypal marker genes of M1 (Nos2) and M2 
(Arg1) activation with Itgam as comparison. Data show mean ± SD, n = 4 
independent samples, each from tissue pooled from eight mice. (h) Region-
dependent variation of cortical and cerebellar microglia in response to the stimulation 
with E.coli, Str, striatum; Hpp, hippocampus; Ctx, cerebral cortex; Cbm, cerebellum. 
(h) Purified microglia were incubated with Escherichia coli strain K-12 and net 
replication of bacteria within microglia computed from counts of bacterial colonies 
derived from microglial cell lysates at indicated timepoints. Data are representative of 
two independent cell preparations and show mean ± SEM, n = 3 replicate samples 
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from one cell preparation. p < 0.05, two-way ANOVA with Bonferroni correction. Str, 
striatum; Hpp, hippocampus; Ctx, cerebral cortex; Cbm, cerebellum. Specific p 
values for all statistical comparisons are presented in Supplementary Table 13. 
 
Figure 6. Regional microglial heterogeneity is comparable to inter-tissue 
macrophage diversity. (a) Principal components analysis of the present regional 
microglial expression datasets and systemic macrophage datasets shows the extent 
of regional microglial heterogeneity relative to macrophage tissue diversity. (b) The 
number of highly-enriched genes (>10-fold, p < 0.05 with FDR correction) in 
microglia compared to peritoneal macrophages was similar for microglia from each 
brain region. (c) Venn diagram showing regional overlap of the genes highly 
enriched in microglia versus peritoneal macrophages. (d) The fold-change (microglia 
versus peritoneal macrophages) in expression of selected genes recently identified 
as signature genes distinguishing microglia from systemic macrophages was 
comparable across brain regions. Str, striatum; Hpp, hippocampus; Ctx, cerebral 
cortex; Cbm, cerebellum. 
 
Figure 7.  Region-specific microglial ageing. (a) Transcripts within the 4 months old 
immunoregulatory and bioenergetics clusters (see Fig 3) were assessed for age-
regulated differential expression and the proportion of age-stable and age-altered 
transcripts determined. (b) Principal components analysis plot of microarray 
expression profiles for purified microglia from discrete brain regions at 4, 12 and 22 
months of age. (c) Sample-to-sample correlation network graph of microarray 
datasets was performed in BioLayout Express3D and clustered using a Markov 
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clustering algorithm. Nodes represent individual samples and edges the degree of 
correlation between their expression patterns. Colours denote discrete clusters. (d) 
Comparison of the number of differentially expressed transcripts (p < 0.05 with FDR 
correction, fold change ≥ 1.5) between different ages for each brain region. (e) 
Comparison of the number of up-regulated and down-regulated transcripts (p < 0.05 
with FDR correction, fold change ≥ 1.5) at 22 vs 12 months in each brain region. (f) 
Hierarchical clustering and heat map of top transcripts with significant age-region 
interaction (p < 0.05, two-way ANOVA with FDR correction). The scaled expression 
value (row Z-score) is displayed in a blue-red colour scheme with red indicating 
higher expression and lower expression in blue. Str, striatum; Hpp, hippocampus; 
Ctx, cerebral cortex; Cbm, cerebellum. 
 
Figure 8. Biological pathways underlying region-specific microglial ageing. (a) 
Transcript-to-transcript correlation network graph of transcripts differentially 
expressed according to age (p < 0.05 with FDR correction) and clustered using a 
Markov clustering algorithm. Nodes represent individual transcripts and edges the 
degree of correlation in expression pattern between them. Colours denote discrete 
clusters. Circled region includes clusters with greater expression in cerebellum 
and/or increasing with age; square region includes clusters with greater expression 
in forebrain regions and/or declining expression with age. (b) Cluster position and 
mean expression profile of transcripts from cluster 2 indicating greater and/or earlier 
age-related changes. (c, d) Interferon pathway genes showing (c) earlier and/or (d) 
greater/selective increases in expression in cerebellar microglia compared to 
forebrain regions during ageing. Data show mean ± SD, n = 4 independent samples, 
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each pooled from tissue from eight mice. *p < 0.05, **p < 0.01, ***p < 0.001 vs 4 
month; #p < 0.05, ##p < 0.01, ###p < 0.001 vs 12 month, two-way ANOVA with 
Bonferroni correction. (e) Heat maps showing microarray expression patterns of 
selected immunoreceptor family genes during ageing arranged according to 
activating (A) or inhibitory (I) classification. Row Z-score intensities represent the 
mean of four independent samples per region and age with red indicating higher 
expression and lower expression in blue. (f) Expression patterns of Cd300 family 
genes show interaction between brain region and age for activating but not inhibitory 
members. Data show mean ± SD, n = 4 independent samples, each pooled from 
tissue from eight mice. *p < 0.05, **p < 0.01, ***p < 0.001 vs 4 month; #p < 0.05, ##p 
< 0.01, ###p < 0.001 vs 12 month, two-way ANOVA with Bonferroni correction. (g, h) 
Cluster position and mean expression profile of transcripts from cluster 14 indicating 
selective decline in expression during ageing in hippocampal microglia. (h) 
Expression profiles of selected genes from cluster 14. Data show mean ± SD, n = 4 
independent samples, each pooled from tissue from eight mice. *p < 0.05, **p < 
0.01, ***p < 0.001 vs 4 month; #p < 0.05, ##p < 0.01, ###p < 0.001 vs 12 month, two-
way ANOVA with Bonferroni correction. Str, striatum; Hpp, hippocampus; Ctx, 
cerebral cortex; Cbm, cerebellum. Specific p values for all statistical comparisons are 









1. Prinz, M. & Mildner, A. Microglia in the CNS: immigrants from another world. Glia 59, 177-
187 (2011). 
2. Prinz, M. & Priller, J. Microglia and brain macrophages in the molecular age: from origin to 
neuropsychiatric disease. Nat Rev Neurosci 15, 300-312 (2014). 
3. Paolicelli, R.C., et al. Synaptic Pruning by Microglia Is Necessary for Normal Brain 
Development. Science (New York, N.Y 333, 1456-1458 (2011). 
4. Schafer, Dorothy P., et al. Microglia Sculpt Postnatal Neural Circuits in an Activity and 
Complement-Dependent Manner. Neuron 74, 691-705 (2012). 
5. Coull, J.A.M., et al. BDNF from microglia causes the shift in neuronal anion gradient 
underlying neuropathic pain. Nature 438, 1017-1021 (2005). 
6. Neumann, H., Kotter, M.R. & Franklin, R.J.M. Debris clearance by microglia: an essential link 
between degeneration and regeneration. Brain 132, 288-295 (2009). 
7. Lalancette-HÃ©bert, M.l., Gowing, G.v., Simard, A., Weng, Y.C. & Kriz, J. Selective Ablation of 
Proliferating Microglial Cells Exacerbates Ischemic Injury in the Brain. The Journal of Neuroscience 
27, 2596-2605 (2007). 
8. Fenn, A.M., Hall, J.C.E., Gensel, J.C., Popovich, P.G. & Godbout, J.P. IL-4 Signaling Drives a 
Unique Arginase+/IL-1β+ Microglia Phenotype and Recruits Macrophages to the Inflammatory CNS: 
Consequences of Age-Related Deficits in IL-4Rα after Traumatic Spinal Cord Injury. The Journal of 
Neuroscience 34, 8904-8917 (2014). 
9. Cardona, A.E., et al. Control of microglial neurotoxicity by the fractalkine receptor. Nat 
Neurosci 9, 917-924 (2006). 
10. Biber, K., Neumann, H., Inoue, K. & Boddeke, H.W. Neuronal 'On' and 'Off' signals control 
microglia. Trends Neurosci 30, 596-602 (2007). 
11. Hickman, S.E., et al. The microglial sensome revealed by direct RNA sequencing. Nat 
Neurosci 16, 1896-1905 (2013). 
12. Butovsky, O., et al. Identification of a unique TGF-[beta]-dependent molecular and functional 
signature in microglia. Nat Neurosci 17, 131-143 (2014). 
13. Lawson, L.J., Perry, V.H., Dri, P. & Gordon, S. Heterogeneity in the distribution and 
morphology of microglia in the normal adult mouse brain. Neuroscience 39, 151-170 (1990). 
14. de Haas, A.H., Boddeke, H.W.G.M. & Biber, K. Region-specific expression of 
immunoregulatory proteins on microglia in the healthy CNS. Glia 56, 888-894 (2008). 
15. Wang, Y., et al. IL-34 is a tissue-restricted ligand of CSF1R required for the development of 
Langerhans cells and microglia. Nat Immunol 13, 753-760 (2012). 
16. Greter, M., et al. Stroma-Derived Interleukin-34 Controls the Development and Maintenance 
of Langerhans Cells and the Maintenance of Microglia. Immunity 37, 1050-1060 (2012). 
17. Karch, C.M. & Goate, A.M. Alzheimer's Disease Risk Genes and Mechanisms of Disease 
Pathogenesis. Biol Psychiatry  (2014). 
18. Yao, P., et al. Coexpression networks identify brain region-specific enhancer RNAs in the 
human brain. Nat Neurosci 18, 1168-1174 (2015). 
19. Chiu, Isaac M., et al. A Neurodegeneration-Specific Gene-Expression Signature of Acutely 
Isolated Microglia from an Amyotrophic Lateral Sclerosis Mouse Model. Cell Reports 4, 385-401 
(2013). 
20. Freeman, T.C., et al. Construction, Visualisation, and Clustering of Transcription Networks 
from Microarray Expression Data. PLoS Comput Biol 3, e206 (2007). 
21. Hume, D.A., Summers, K.M., Raza, S., Baillie, J.K. & Freeman, T.C. Functional clustering and 
lineage markers: Insights into cellular differentiation and gene function from large-scale microarray 
studies of purified primary cell populations. Genomics 95, 328-338 (2010). 
22. Takaoka, A., et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate 
immune response. Nature 448, 501-505 (2007). 
50 
 
23. Ghesquiere, B., Wong, B.W., Kuchnio, A. & Carmeliet, P. Metabolism of stromal and immune 
cells in health and disease. Nature 511, 167-176 (2014). 
24. Linnartz, B., Wang, Y. & Neumann, H. Microglial Immunoreceptor Tyrosine-Based Activation 
and Inhibition Motif Signaling in Neuroinflammation. International Journal of Alzheimer's Disease 
2010 (2010). 
25. Freilich, R.W., Woodbury, M.E. & Ikezu, T. Integrated Expression Profiles of mRNA and 
miRNA in Polarized Primary Murine Microglia. PLoS ONE 8, e79416 (2013). 
26. Mathelier, A., et al. JASPAR 2014: an extensively expanded and updated open-access 
database of transcription factor binding profiles. Nucleic Acids Research 42, D142-D147 (2014). 
27. Frith, M.C., et al. Detection of functional DNA motifs via statistical over-representation. 
Nucleic Acids Research 32, 1372-1381 (2004). 
28. Huss, J.M., Torra, I.P., Staels, B., Giguère, V. & Kelly, D.P. Estrogen-Related Receptor α 
Directs Peroxisome Proliferator-Activated Receptor α Signaling in the Transcriptional Control of 
Energy Metabolism in Cardiac and Skeletal Muscle. Molecular and Cellular Biology 24, 9079-9091 
(2004). 
29. Mootha, V.K., et al. Errα and Gabpa/b specify PGC-1α-dependent oxidative phosphorylation 
gene expression that is altered in diabetic muscle. Proceedings of the National Academy of Sciences 
of the United States of America 101, 6570-6575 (2004). 
30. Pearen, M.A. & Muscat, G.E.O. Minireview: Nuclear Hormone Receptor 4A Signaling: 
Implications for Metabolic Disease. Molecular Endocrinology 24, 1891-1903 (2010). 
31. Archer, M.C. Role of Sp Transcription Factors in the Regulation of Cancer Cell Metabolism. 
Genes & Cancer 2, 712-719 (2011). 
32. Francis, G.A., Fayard, E., Picard, F. & Auwerx, J. NUCLEAR RECEPTORS AND THE CONTROL OF 
METABOLISM. Annual Review of Physiology 65, 261-311 (2003). 
33. Griffin, M.J., et al. Early B-cell Factor-1 (EBF1) Is a Key Regulator of Metabolic and 
Inflammatory Signaling Pathways in Mature Adipocytes. Journal of Biological Chemistry 288, 35925-
35939 (2013). 
34. Chen, B.-S., Yang, S.-K., Lan, C.-Y. & Chuang, Y.-J. A systems biology approach to construct 
the gene regulatory network of systemic inflammation via microarray and databases mining. BMC 
Medical Genomics 1, 46 (2008). 
35. Natoli, G., Ghisletti, S. & Barozzi, I. The genomic landscapes of inflammation. Genes & 
Development 25, 101-106 (2011). 
36. Schnell, L., Fearn, S., Klassen, H., Schwab, M.E. & Perry, V.H. Acute inflammatory responses 
to mechanical lesions in the CNS: differences between brain and spinal cord. European Journal of 
Neuroscience 11, 3648-3658 (1999). 
37. Hart, A.D., Wyttenbach, A., Hugh Perry, V. & Teeling, J.L. Age related changes in microglial 
phenotype vary between CNS regions: Grey versus white matter differences. Brain, Behavior, and 
Immunity 26, 754-765 (2012). 
38. Gosselin, D., et al. Environment drives selection and function of enhancers controlling tissue-
specific macrophage identities. Cell 159, 1327-1340 (2014). 
39. Bernhart, E., et al. Lysophosphatidic acid receptor activation affects the C13NJ microglia cell 
line proteome leading to alterations in glycolysis, motility, and cytoskeletal architecture. 
PROTEOMICS 10, 141-158 (2010). 
40. Stocking, C. & Kozak, C.A. Endogenous retroviruses. Cellular and Molecular Life Sciences 65, 
3383-3398 (2008). 
41. Yu, P., et al. Nucleic Acid-Sensing Toll-like Receptors Are Essential for the Control of 
Endogenous Retrovirus Viremia and ERV-Induced Tumors. Immunity 37, 867-879. 
42. Lee, K.H., Horiuchi, M., Itoh, T., Greenhalgh, D.G. & Cho, K. Cerebellum-specific and age-




43. Baillie, J.K., et al. Somatic retrotransposition alters the genetic landscape of the human 
brain. Nature 479, 534-537 (2011). 
44. Johnson-Wood, K., et al. Amyloid precursor protein processing and AÎ²(42) deposition in a 
transgenic mouse model ofâ€‰Alzheimerâ€‰disease. Proceedings of the National Academy of 
Sciences of the United States of America 94, 1550-1555 (1997). 
45. Damani, M.R., et al. Age-related alterations in the dynamic behavior of microglia. Aging Cell 
10, 263-276 (2011). 
46. Streit, W., Braak, H., Xue, Q.-S. & Bechmann, I. Dystrophic (senescent) rather than activated 
microglial cells are associated with tau pathology and likely precede neurodegeneration in 
Alzheimer’s disease. Acta Neuropathologica 118, 475-485 (2009). 
47. Sleimen-Malkoun, R., Jean-Jacques, T. & Hong, S.L. Aging induced loss of complexity and 
dedifferentiation: Consequences for coordination dynamics within and between brain, muscular and 
behavioral levels. Frontiers in Aging Neuroscience 6 (2014). 
48. Goh, J.O.S. Functional Dedifferentiation and Altered Connectivity in Older Adults: Neural 
Accounts of Cognitive Aging. Aging Dis 2, 30-48 (2011). 
49. Park, D.C., et al. Aging reduces neural specialization in ventral visual cortex. Proceedings of 
the National Academy of Sciences of the United States of America 101, 13091-13095 (2004). 
50. Davies, L.C., Jenkins, S.J., Allen, J.E. & Taylor, P.R. Tissue-resident macrophages. Nature 
immunology 14, 986-995 (2013). 
51. Lein, E.S., et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature 445, 
168-176 (2007). 
52. Huang, D.W., Sherman, B.T. & Lempicki, R.A. Systematic and integrative analysis of large 
gene lists using DAVID bioinformatics resources. Nat. Protocols 4, 44-57 (2008). 
53. Merico, D., Isserlin, R., Stueker, O., Emili, A. & Bader, G.D. Enrichment Map: A Network-
Based Method for Gene-Set Enrichment Visualization and Interpretation. PLoS ONE 5, e13984 
(2010). 
54. Cline, M.S., et al. Integration of biological networks and gene expression data using 
Cytoscape. Nat. Protocols 2, 2366-2382 (2007). 
55. Eden, E., Navon, R., Steinfeld, I., Lipson, D. & Yakhini, Z. GOrilla: a tool for discovery and 
visualization of enriched GO terms in ranked gene lists. BMC Bioinformatics 10, 48 (2009). 
 








